APA

Tse B. W. C., Volpert M., Ratther E., Stylianou N., Nouri M., McGowan K., Lehman M. L., McPherson S. J., Roshan-Moniri M., Butler M. S., Caradec J., Gregory-Evans C. Y., McGovern J., Das R., Takhar M., Erho N., Alshalafa M., Davicioni E., Schaeffer E. M., Jenkins R. B., Ross A. E., Karnes R. J., Den R. B., Fazli L., Gregory P. A., Gleave M. E., Williams E. D., Rennie P. S., Buttyan R., Gunter J. H., Selth L. A., Russell P. J., Nelson C. C. & Hollier B. G. (20170918). Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality. : Oncogene.

Chicago

Tse B W C, Volpert M, Ratther E, Stylianou N, Nouri M, McGowan K, Lehman M L, McPherson S J, Roshan-Moniri M, Butler M S, Caradec J, Gregory-Evans C Y, McGovern J, Das R, Takhar M, Erho N, Alshalafa M, Davicioni E, Schaeffer E M, Jenkins R B, Ross A E, Karnes R J, Den R B, Fazli L, Gregory P A, Gleave M E, Williams E D, Rennie P S, Buttyan R, Gunter J H, Selth L A, Russell P J, Nelson C C and Hollier B G. 20170918. Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality. : Oncogene.

Harvard

Tse B. W. C., Volpert M., Ratther E., Stylianou N., Nouri M., McGowan K., Lehman M. L., McPherson S. J., Roshan-Moniri M., Butler M. S., Caradec J., Gregory-Evans C. Y., McGovern J., Das R., Takhar M., Erho N., Alshalafa M., Davicioni E., Schaeffer E. M., Jenkins R. B., Ross A. E., Karnes R. J., Den R. B., Fazli L., Gregory P. A., Gleave M. E., Williams E. D., Rennie P. S., Buttyan R., Gunter J. H., Selth L. A., Russell P. J., Nelson C. C. and Hollier B. G. (20170918). Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality. : Oncogene.

MLA

Tse B W C, Volpert M, Ratther E, Stylianou N, Nouri M, McGowan K, Lehman M L, McPherson S J, Roshan-Moniri M, Butler M S, Caradec J, Gregory-Evans C Y, McGovern J, Das R, Takhar M, Erho N, Alshalafa M, Davicioni E, Schaeffer E M, Jenkins R B, Ross A E, Karnes R J, Den R B, Fazli L, Gregory P A, Gleave M E, Williams E D, Rennie P S, Buttyan R, Gunter J H, Selth L A, Russell P J, Nelson C C and Hollier B G. Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality. : Oncogene. 20170918.